Skip to main content

Table 1 ZnT proteins- expression and physiological roles.

From: Mechanism and Regulation of Cellular Zinc Transport

 

Expression pattern

Cellular distribution

Disease model

Altered expression phenotype

Ref

ZnT-1

Ubiquitous

Plasma membrane

 

Overexpression: reduced [Zn2+] i and enhanced resistance against Zn2+ toxicity, KO: Lethal at embryonic stage,

(37,42,43,71)

ZnT-2

small intestine, kidney, placenta, pancreas, testis, seminal vesicles, and mammary gland

Vesicles, lysosomes

 

Overexpression: enhanced lysosomal and vesicular Zn2+ accumulation

(72,73)

ZnT-3

brain

Synaptic vesicles (Glutamatergic and GABAergic)

 

KO: synaptic Zn2+ deficiency, enhanced susceptibility to seizure, loss of gender specific Alzheimer’s disease plaque formation in a mouse model, decreased susceptibility to amyloid angiopathy

(49,74)

ZnT-4

mammary gland, brain, small intestine and mast cells

Intracellular compartments

Lethal milk syndrome in mice, Asthma (mice), Alzheimer’s disease

 

(75–79)

ZnT-5

Pancreatic β-cells, intestine, heart brain, liver, kidney

Insulin secretory vesicles, Golgi Spliced isoform: plasma membrane Complexed with ZnT-6

 

KO: poor growth, osteopenia, male specific fatal arrhythmias. Essential for folding and secretion of Zn2+ -binding enzymes.

(53–55,59,80)

ZnT-6

liver, brain, and small Intestine

Complexed with ZnT-5

Alzheimer’s disease (mice)

 

(53,57,79)

ZnT-7

small intestine, liver, retina, spleen, kidney, and lung

Golgi

 

Essential for folding and secretion of Zn2+ -binding enzymes,

(54,81,82)

ZnT-8

Pancreatic β-cells

Insulin secretory vesicles

Polymorphism marker in diabetes type II

Overexpression: enhances glucose dependent insulin secretion

(60–62)